Published in Arch Otolaryngol Head Neck Surg on March 01, 1990
Autoimmune neutropenia. Blood (1993) 1.52
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells. J Clin Invest (1973) 1.29
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Chlorpropamide-induced immune hemolytic anemia. N Engl J Med (1970) 1.20
Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis. J Clin Invest (1978) 1.18
Pulmonary and hepatic complications of methotrexate therapy of psoriasis. JAMA (1971) 1.14
Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin Invest (1973) 1.10
The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor. Br J Haematol (1972) 1.10
A large keratinizing dentigerous cyst: report of case. J Oral Surg (1971) 1.06
Olfactory neuroblastoma (esthesioneuroblastoma): a light and ultrastructural study of two cases. Cancer (1979) 1.04
Hemorrhagic thrombocythemia; control of postsplenectomy thrombocytosis with melphalan. Blood (1970) 1.03
Immunochemistry and immunogenicity of low molecular weight human salivary mucin. Arch Oral Biol (1991) 1.02
Felty's syndrome without splenomegaly. Am J Med (1979) 0.94
Home as a place to die. Am J Nurs (1980) 0.93
Sudden death during doxorubicin administration. Cancer (1979) 0.92
Complement-dependent immune adherence measured with human granulocytes: changes in the antigenic nature of red cell-bound C3 produced by incubation in human serum. Clin Immunol Immunopathol (1973) 0.91
Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease. N Engl J Med (1987) 0.88
Immunologic mechanisms of hemolysis in autoimmune hemolytic anemia. Pathobiol Annu (1978) 0.86
Transient acquired factor X deficiency associated with pneumonia. N Y State J Med (1984) 0.86
Recurrent thrombocytopenia following idiopathic thrombocytopenic purpura. The importance of platelet-bound IgG in establishing cause. Arch Intern Med (1980) 0.86
Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele. J Thorac Cardiovasc Surg (1997) 0.84
Immunochemistry of high molecular-weight human salivary mucin. Arch Oral Biol (1990) 0.84
A nonfunctioning paraganglioma of vagus nerve: an ultrastructural study. Cancer (1979) 0.83
I and i antigens on normal and leukemic leukocytes. Cancer (1978) 0.82
Autoimmune granulocytopenia. Annu Rev Med (1980) 0.82
Felty's syndrome: effects of splenectomy upon granulocyte count and granulocyte-associated IgG. Ann Intern Med (1981) 0.81
Chondroblastic osteosarcoma of the larynx. Arch Otolaryngol (1978) 0.81
Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells. Blood (1977) 0.80
Replication of type I herpes simplex virus in primary cultures of hairy cell leukemic leukocytes. Am J Pathol (1978) 0.80
Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets. Blood (1987) 0.80
Endogenous carbon monoxide production measured by gas-phase analysis: an estimation of heme catabolic rate. J Lab Clin Med (1971) 0.80
Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies. Transfusion (1991) 0.79
Alpha-interferon for severe cold agglutinin disease. Ann Intern Med (1989) 0.79
Primary hyperparathyroidism and laryngeal carcinoma: a cause of associated hypercalcemia. Laryngoscope (1981) 0.79
Activation of human complement by immunoglobulin G antigranulocyte antibody. J Clin Invest (1982) 0.79
Evaluating the superior vena cava syndrome. JAMA (1981) 0.79
Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders. Br J Haematol (1987) 0.78
Medical management of chronic cancer pain. JAMA (1979) 0.78
Use of total lymphoid irradiation (TLI) in studies of the T cell-dependence of autoantibody production in rheumatoid arthritis. J Immunol (1984) 0.78
Complement-activating antineutrophil antibody in systemic lupus erythematosus. Am J Med (1985) 0.78
Two biochemical markers in lymphocyte subpopulations. Br J Haematol (1976) 0.77
Human lymphocyte complement receptors. Stimulation of lymphocyte RNA synthesis by complement-coated human red cells. Clin Immunol Immunopathol (1977) 0.77
Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation. ASAIO J (1994) 0.77
Failure of splenectomy in Felty's syndrome. The role of antibodies supporting granulocyte lysis by lymphocytes. N Engl J Med (1981) 0.77
Autoimmune neutropenia in Hodgkin's disease. Arch Intern Med (1982) 0.77
The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels. Trans Assoc Am Physicians (1976) 0.77
Human lymphocyte complement receptors. Quantitative requirements for C3 of normal and chronic lymphocyte leukemia lymphocytes. J Clin Invest (1977) 0.76
Light chain composition of serum granulocyte binding immunoglobulins. Am J Hematol (1991) 0.76
Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b. Blood (1988) 0.76
Diving decompression fails to activate complement. Undersea Hyperb Med (1997) 0.76
Melphalan therapy of polycythemia vera. Blood (1970) 0.76
Antidepressant therapies and the cardiac patient: a review. Mil Med (1982) 0.75
Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia). Blood (1979) 0.75
In vitro activation of human complement by nitrogen bubbles. Undersea Biomed Res (1991) 0.75
Parathyroid adenoma. Ear Nose Throat J (1983) 0.75
Quantitation of warm reactive IgG antilymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol (1980) 0.75
Spurious neutropenia: ethylenediaminetetraacetate-dependent in vitro neutrophil agglutination. N Y State J Med (1991) 0.75
Immune neutropenia. Prog Clin Biol Res (1984) 0.75
Renal oncocytoma: long-term follow-up and flow cytometric DNA analysis. J Surg Oncol (1991) 0.75
Splenectomy in Felty's syndrome. Ann Intern Med (1982) 0.75
[Hospice: part II]. Kango (1982) 0.75
Granulomatous laryngitis of unknown etiology. Laryngoscope (1980) 0.75
T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1983) 0.75
Immune hemolytic anemias. Mod Treat (1971) 0.75
Granulocytes in Felty's syndrome. Ann Intern Med (1977) 0.75
Flecanide-induced immune neutropenia. Documentation of a hapten-mediated mechanism of cell destruction. Arch Intern Med (1987) 0.75
Antibody-dependent lymphocyte-mediated granulocyte cytotoxicity in man. Blood (1978) 0.75
Association of a thyroglossal duct cyst and a dermoid cyst in the neck. A case report. Ann Otol Rhinol Laryngol (1981) 0.75
In vitro activation of human complement by polyacrilonitrile dialyzer membrane assayed by complement binding to bystander red cells. ASAIO J (1992) 0.75
Bifid epiglottis. Report of a case. Arch Otolaryngol (1972) 0.75
Primary amyloidosis, pure red cell aplasia, and Kaposi's sarcoma in a single patient. Cancer (1979) 0.75
von Willebrand's variant (type II Buffalo). Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin. Am J Clin Pathol (1990) 0.75
Teardrop-shaped red cells in autoimmune hemolytic anemia. Am J Hematol (1986) 0.75
Chronic ulcerative stomatitis associated with a specific immunologic marker. J Am Acad Dermatol (1990) 0.75
Effect of RBCs on the activation of human complement by heparin-protamine complexes. Blood (1988) 0.75